Form 4 for VRCA Verrica Pharmaceuticals Inc.
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001415889-24-008541 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-19 | 2024-03-15 | VRCA | Kohler Terry | CFO | A - Grant | $0.00 | +40.0K | 74.4K | +116% | $0 |
| D | 2024-03-19 | 2024-03-15 | VRCA | Kohler Terry | CFO | A - Grant | $0.00 | +80.0K | 80.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | A | A | 40,000 | $0.00 | 74,416 | D | — | — | (F1) Represents a restricted stock unit ("RSU") award. The RSUs shall vest in equal annual installments on March 15, 2025, March 15, 2026, March 15, 2027 and March 15, 2028 subject to the Reporting Person's continuous service through each applicable date. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2024-03-15 | A | A | 80,000 | $0.00 | 80,000 | D | $4.80 · — to 2034-03-15 | 80,000 Common Stock | (F2) 25% of the total shares subject to the option shall vest on March 15, 2025 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. |